Cite
Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV : an international cohort collaboration [plus Supplementary appendix]
MLA
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, et al. Incidence of Switching to Second-Line Antiretroviral Therapy and Associated Factors in Children with HIV : An International Cohort Collaboration [plus Supplementary Appendix]. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......932..c493b5264f95022b059aa540142d514a&authtype=sso&custid=ns315887.
APA
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Collins, I. J., Wools-Kaloustian, K., Goodall, R., Smith, C., Abrams, E. J., Ben-Farhat, J., Balkan, S., Davies, M. A., Edmonds, A., Leroy, V., Nuwagaba-Biribonwoha, H., Patel, K., Paul, M. E., Pinto, J., Conejo, P. R., Sohn, A., Van Dyke, R., Vreeman, R., … Jourdain, G. (2019). Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV : an international cohort collaboration [plus Supplementary appendix].
Chicago
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, I.J. Collins, K. Wools-Kaloustian, R. Goodall, C. Smith, E.J. Abrams, J. Ben-Farhat, et al. 2019. “Incidence of Switching to Second-Line Antiretroviral Therapy and Associated Factors in Children with HIV : An International Cohort Collaboration [plus Supplementary Appendix],” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......932..c493b5264f95022b059aa540142d514a&authtype=sso&custid=ns315887.